Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Proverb comprehension in individuals with agenesis of the corpus callosum.

Rehmel JL, Brown WS, Paul LK.

Brain Lang. 2016 Sep;160:21-9. doi: 10.1016/j.bandl.2016.07.001. Epub 2016 Jul 21.

PMID:
27448531
2.

Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors.

Cannady EA, Wang MD, Friedrich S, Rehmel JL, Yi P, Small DS, Zhang W, Suico JG.

Pharmacol Res Perspect. 2015 Oct;3(5):e00179. doi: 10.1002/prp2.179. Epub 2015 Oct 12.

3.

Investigational small-molecule drug selectively suppresses constitutive CYP2B6 activity at the gene transcription level: physiologically based pharmacokinetic model assessment of clinical drug interaction risk.

Zamek-Gliszczynski MJ, Mohutsky MA, Rehmel JL, Ke AB.

Drug Metab Dispos. 2014 Jun;42(6):1008-15. doi: 10.1124/dmd.114.057018. Epub 2014 Mar 21.

PMID:
24658455
4.

Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450.

Rehmel JL, Eckstein JA, Farid NA, Heim JB, Kasper SC, Kurihara A, Wrighton SA, Ring BJ.

Drug Metab Dispos. 2006 Apr;34(4):600-7. Epub 2006 Jan 13.

PMID:
16415119

Supplemental Content

Loading ...
Support Center